Ignite Creation Date:
2024-05-06 @ 3:19 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04596995
Status:
TERMINATED
Last Update Posted:
2024-02-05
First Post:
2020-10-15
Brief Title:
A Study to Investigate the Long-term Safety Tolerability and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia ITP
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-06
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-21
Completion Date Type:
ACTUAL
First Submit Date:
2020-10-15
First Submit QC Date:
October 15 2020
Study First Post Date:
2020-10-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2024-02-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-02
Last Update Post Date:
2024-02-05
Last Update Post Date Type:
ACTUAL